BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

498 related articles for article (PubMed ID: 11124817)

  • 1. Furosemide-induced natriuresis as a test to identify cirrhotic patients with refractory ascites.
    Spahr L; Villeneuve JP; Tran HK; Pomier-Layrargues G
    Hepatology; 2001 Jan; 33(1):28-31. PubMed ID: 11124817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The significance of urine sodium measurement after furosemide administration in diuretics-unresponsive patients with liver cirrhosis].
    Cho HS; Park GT; Kim YH; Shim SG; Kim JB; Lee OY; Choi HS; Hahm JS; Lee MH
    Taehan Kan Hakhoe Chi; 2003 Dec; 9(4):324-31. PubMed ID: 14695699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Trial: High-dose furosemide plus small-volume hypertonic saline solutions vs. repeated paracentesis as treatment of refractory ascites.
    Licata G; Tuttolomondo A; Licata A; Parrinello G; Di Raimondo D; Di Sciacca R; Cammà C; Craxì A; Paterna S; Pinto A
    Aliment Pharmacol Ther; 2009 Aug; 30(3):227-35. PubMed ID: 19438847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral furosemide-induced natriuresis: a potential method for identifying cirrhotic patients with refractory ascites.
    Kountouras J; Zavos C; Touloumis L; Chatzopoulos D
    Liver Int; 2010 Oct; 30(9):1395; author reply 1395-6. PubMed ID: 20731771
    [No Abstract]   [Full Text] [Related]  

  • 5. A pathophysiological interpretation of unresponsiveness to spironolactone in a stepped-care approach to the diuretic treatment of ascites in nonazotemic cirrhotic patients.
    Gatta A; Angeli P; Caregaro L; Menon F; Sacerdoti D; Merkel C
    Hepatology; 1991 Aug; 14(2):231-6. PubMed ID: 1860680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Refractory ascites: definition, pathogenesis and treatment.
    Laffi G; La Villa G; Pinzani M; Foschi M; Carloni V; Casini Raggi V; Gentilini P
    Ann Ital Med Int; 1993; 8(1):38-46. PubMed ID: 8485009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Biological factors influencing response to diuretics in patients with cirrhosis and ascites].
    Lenaerts A; Codden T; Henry JP; Van Cauter J; Meunier JC; Ligny G
    Gastroenterol Clin Biol; 2001 Mar; 25(3):268-72. PubMed ID: 11395674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of ascites in cirrhosis. Diuretics, peritoneovenous shunt, and large-volume paracentesis.
    Arroyo V; Ginès P; Planas R
    Gastroenterol Clin North Am; 1992 Mar; 21(1):237-56. PubMed ID: 1568775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal effects of treatment with diuretics, octreotide or both, in non-azotemic cirrhotic patients with ascites.
    Kalambokis G; Economou M; Fotopoulos A; Bokharhii JA; Katsaraki A; Tsianos EV
    Nephrol Dial Transplant; 2005 Aug; 20(8):1623-9. PubMed ID: 15886218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and neurohumoral response to posture, physical exercise, and ascites treatment in Child-Pugh C liver cirrhosis: randomized prospective trial.
    Degoricija V; Zjacic-Rotkvic V; Marout J; Sefer S; Troskot B
    Croat Med J; 2003 Apr; 44(2):178-86. PubMed ID: 12698509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
    Licata G; Di Pasquale P; Parrinello G; Cardinale A; Scandurra A; Follone G; Argano C; Tuttolomondo A; Paterna S
    Am Heart J; 2003 Mar; 145(3):459-66. PubMed ID: 12660669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of ascites in patients with liver cirrhosis without neither hyponatremia nor renal insufficiency. Results of a randomized study comparing diuretics and punctures compensated by albumin].
    Hagège H; Ink O; Ducreux M; Pelletier G; Buffet C; Etienne JP
    Gastroenterol Clin Biol; 1992; 16(10):751-5. PubMed ID: 1478401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 'Diuretic-resistant' ascites. Observations on pathogenesis.
    Rector WG
    Arch Intern Med; 1986 Aug; 146(8):1597-600. PubMed ID: 3729643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of cirrhotic ascites.
    Schouten J; Michielsen PP
    Acta Gastroenterol Belg; 2007; 70(2):217-22. PubMed ID: 17715638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary prostaglandin E2 excretion, sodium retention, and diuretic responsiveness in patients with chronic liver disease.
    Rector WG
    Am J Gastroenterol; 1987 Apr; 82(4):347-51. PubMed ID: 3471082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of clonidine on diuretic response in ascitic patients with cirrhosis and activation of sympathetic nervous system.
    Lenaerts A; Codden T; Meunier JC; Henry JP; Ligny G
    Hepatology; 2006 Oct; 44(4):844-9. PubMed ID: 17006921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Paracentesis combined with albumin infusion in the treatment of tense ascites in cirrhotic patients].
    Chesta J; Brahm J; Latorre R; Gidi J; Hurtado C; Antezana C; Novoa X; Velasco M
    Rev Med Chil; 1990 Aug; 118(8):874-80. PubMed ID: 2152231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Refractory ascites: can it be defined only by the response to furosemide and spironolactone?
    Kalambokis G; Tsianos EV
    Liver Int; 2010 Oct; 30(9):1394; author reply 1395-6. PubMed ID: 20738777
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of a selective vasopressin V2 receptor antagonist, satavaptan, on ascites recurrence after paracentesis in patients with cirrhosis.
    Wong F; Gines P; Watson H; Horsmans Y; Angeli P; Gow P; Minini P; Bernardi M
    J Hepatol; 2010 Aug; 53(2):283-90. PubMed ID: 20541828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Furosemide and metolazone: a highly effective diuretic combination].
    Furrer J; Hess OM; Kuhlmann U; Satz N; Siegenthaler W
    Schweiz Med Wochenschr; 1980 Nov; 110(48):1825-9. PubMed ID: 7280609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.